JP2015160820A - 慢性腎障害治療のための多能性幹細胞 - Google Patents

慢性腎障害治療のための多能性幹細胞 Download PDF

Info

Publication number
JP2015160820A
JP2015160820A JP2014035931A JP2014035931A JP2015160820A JP 2015160820 A JP2015160820 A JP 2015160820A JP 2014035931 A JP2014035931 A JP 2014035931A JP 2014035931 A JP2014035931 A JP 2014035931A JP 2015160820 A JP2015160820 A JP 2015160820A
Authority
JP
Japan
Prior art keywords
cells
cell
negative
muse
pluripotent stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014035931A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015160820A5 (enExample
Inventor
正順 吉田
Masayori Yoshida
正順 吉田
真理 出澤
Mari Idesawa
真理 出澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tohoku University NUC
Clio Inc
Original Assignee
Tohoku University NUC
Clio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tohoku University NUC, Clio Inc filed Critical Tohoku University NUC
Priority to JP2014035931A priority Critical patent/JP2015160820A/ja
Priority to US14/695,872 priority patent/US20160058800A1/en
Publication of JP2015160820A publication Critical patent/JP2015160820A/ja
Priority to US15/413,129 priority patent/US10293003B2/en
Publication of JP2015160820A5 publication Critical patent/JP2015160820A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2014035931A 2014-02-26 2014-02-26 慢性腎障害治療のための多能性幹細胞 Pending JP2015160820A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2014035931A JP2015160820A (ja) 2014-02-26 2014-02-26 慢性腎障害治療のための多能性幹細胞
US14/695,872 US20160058800A1 (en) 2014-02-26 2015-04-24 Pluripotent stem cell for treatment of chronic kidney disease
US15/413,129 US10293003B2 (en) 2014-02-26 2017-01-23 Multilineage-differentiating stress enduring (MUSE) cells for treatment of chronic kidney disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014035931A JP2015160820A (ja) 2014-02-26 2014-02-26 慢性腎障害治療のための多能性幹細胞

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018126976A Division JP7072777B2 (ja) 2018-07-03 2018-07-03 慢性腎障害治療のための多能性幹細胞

Publications (2)

Publication Number Publication Date
JP2015160820A true JP2015160820A (ja) 2015-09-07
JP2015160820A5 JP2015160820A5 (enExample) 2017-02-09

Family

ID=54184165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014035931A Pending JP2015160820A (ja) 2014-02-26 2014-02-26 慢性腎障害治療のための多能性幹細胞

Country Status (2)

Country Link
US (2) US20160058800A1 (enExample)
JP (1) JP2015160820A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018162308A (ja) * 2018-07-03 2018-10-18 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
WO2021085639A1 (ja) * 2019-10-31 2021-05-06 株式会社生命科学インスティテュート 多能性幹細胞による間質性膀胱炎の治療
JP2023001294A (ja) * 2016-07-01 2023-01-04 国立大学法人東北大学 臓器線維症の予防または治療剤

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107050050B (zh) * 2017-04-19 2020-06-19 樊均明 一种肾小球和肾小管复合损伤的猕猴慢性肾病模型的建立方法
SG11201912831TA (en) * 2017-06-20 2020-01-30 Univ Nagoya Nat Univ Corp Amelioration and treatment of brain disorder resulting from fetal growth retardation using pluripotent stem cells
EP4061400A4 (en) * 2019-11-20 2024-01-10 Cornell University Generation of kidney glomerular specific endothelial cells and methods of use

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003013588A1 (en) * 2001-08-08 2003-02-20 Kaken Pharmaceutical Co., Ltd. Kidney regeneration material comprising cells and cell growth factor
JP2012100662A (ja) * 2011-12-05 2012-05-31 Sapporo Medical Univ 細胞増殖方法ならびに組織の修復および再生のための医薬
JP2012139246A (ja) * 2009-07-15 2012-07-26 Mari Idesawa 生体組織から単離できる多能性幹細胞
WO2014027684A1 (ja) * 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2521217C (en) * 2003-04-01 2013-05-14 United States Of America Department Of Veteran's Affairs Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003013588A1 (en) * 2001-08-08 2003-02-20 Kaken Pharmaceutical Co., Ltd. Kidney regeneration material comprising cells and cell growth factor
JP2012139246A (ja) * 2009-07-15 2012-07-26 Mari Idesawa 生体組織から単離できる多能性幹細胞
JP2012100662A (ja) * 2011-12-05 2012-05-31 Sapporo Medical Univ 細胞増殖方法ならびに組織の修復および再生のための医薬
WO2014027684A1 (ja) * 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
INFRAMMATION AND REGENERATION, 2010, VOL.30, NO.4, P.360, JPN6017032530, ISSN: 0003914535 *
MOL. CELL BIOCHEM., 2012, VOL.368, PP.137-145, JPN6017032529, ISSN: 0003914534 *
PERIPHERAL NERVE, 2012, VOL.23, NO.2, PP.135-139, JPN6017034978, ISSN: 0003914537 *
東北医学雑誌, 2013, VOL.125, NO.1, PP.107-109, JPN6017032532, ISSN: 0003914536 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023001294A (ja) * 2016-07-01 2023-01-04 国立大学法人東北大学 臓器線維症の予防または治療剤
JP2018162308A (ja) * 2018-07-03 2018-10-18 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
JP7072777B2 (ja) 2018-07-03 2022-05-23 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
WO2021085639A1 (ja) * 2019-10-31 2021-05-06 株式会社生命科学インスティテュート 多能性幹細胞による間質性膀胱炎の治療
JPWO2021085639A1 (enExample) * 2019-10-31 2021-05-06
US12491211B2 (en) 2019-10-31 2025-12-09 Tohoku University Therapy for interstitial cystitis by pluripotent stem cells

Also Published As

Publication number Publication date
US10293003B2 (en) 2019-05-21
US20170128498A1 (en) 2017-05-11
US20160058800A1 (en) 2016-03-03

Similar Documents

Publication Publication Date Title
JP5968442B2 (ja) 心筋梗塞の修復再生を誘導する多能性幹細胞
US10293003B2 (en) Multilineage-differentiating stress enduring (MUSE) cells for treatment of chronic kidney disease
JP6519038B2 (ja) 脳梗塞治療のための多能性幹細胞
Yang et al. Subarachnoid transplantation of human umbilical cord mesenchymal stem cell in rodent model with subacute incomplete spinal cord injury: preclinical safety and efficacy study
JP6018081B2 (ja) 自己免疫および炎症性疾患におけるリンパ系内投与用の脂肪由来間葉系幹細胞
EP2709636A2 (en) Use of mesenchymal stem cells for the improvement of affective and cognitive function
ES2846795T3 (es) Células madres pluripotentes para el tratamiento de la úlcera cutánea diabética
JP7072777B2 (ja) 慢性腎障害治療のための多能性幹細胞
JP2018511599A (ja) 細胞増殖の刺激のための方法及び組成物、ならびにｆｇｆ２アイソフォームの生物学的に活性な混合物の提供
JP2023001294A (ja) 臓器線維症の予防または治療剤
EP3492091B1 (en) "muse" cells as prophylactic or therapeutic agent for aneurysm
JP6604492B2 (ja) 脳梗塞治療のための多能性幹細胞
JP2021073305A (ja) 慢性腎障害治療のための多能性幹細胞
US20230270790A1 (en) Pluripotent stem cells effective for treatment of motor neuron disease (mnd)
JP7618233B2 (ja) 脳血管性認知症の治療または予防剤
WO2019216380A1 (ja) 脊髄損傷の治療剤
WO2025170054A1 (ja) 脊髄梗塞治療のための多能性幹細胞
US20220323509A1 (en) Therapeutic agent for myocarditis
WO2021085639A1 (ja) 多能性幹細胞による間質性膀胱炎の治療
Little et al. Potential of the Side Population in Regenerative Nephrology

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20140327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161221

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170829

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20171003

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171026

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180703

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20180703

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20180717

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20180904

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20180911

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20181109

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20181113

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20190129

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20190416

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20190903

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20190917

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191115

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20200218

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20200324

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20200324

C609 Written withdrawal of request for trial/appeal

Free format text: JAPANESE INTERMEDIATE CODE: C609

Effective date: 20200423